117 related articles for article (PubMed ID: 9209666)
1. Phase II trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma.
Bedikian AY; Legha SS; Eton O; Buzaid AC; Papadopoulos N; Coates S; Simmons T; Neefe J; von Roemeling R
Ann Oncol; 1997 Apr; 8(4):363-7. PubMed ID: 9209666
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma.
Bedikian AY; Legha SS; Eton O; Buzaid AC; Papadopoulos N; Plager C; McIntyre S; Viallet J
Anticancer Drugs; 1999 Sep; 10(8):735-9. PubMed ID: 10573206
[TBL] [Abstract][Full Text] [Related]
3. Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.
Treat J; Johnson E; Langer C; Belani C; Haynes B; Greenberg R; Rodriquez R; Drobins P; Miller W; Meehan L; McKeon A; Devin J; von Roemeling R; Viallet J
J Clin Oncol; 1998 Nov; 16(11):3524-7. PubMed ID: 9817270
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer.
Miller VA; Ng KK; Grant SC; Kindler H; Pizzo B; Heelan RT; von Roemeling R; Kris MG
Ann Oncol; 1997 Dec; 8(12):1269-71. PubMed ID: 9496394
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of tirapazamine in combination with cisplatin in a single dose every 3 weeks in patients with solid tumors.
Johnson CA; Kilpatrick D; von Roemeling R; Langer C; Graham MA; Greenslade D; Kennedy G; Keenan E; O'Dwyer PJ
J Clin Oncol; 1997 Feb; 15(2):773-80. PubMed ID: 9053504
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer.
Maluf FC; Leiser AL; Aghajanian C; Sabbatini P; Pezzulli S; Chi DS; Wolf JK; Levenback C; Loh E; Spriggs DR
Int J Gynecol Cancer; 2006; 16(3):1165-71. PubMed ID: 16803501
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
[TBL] [Abstract][Full Text] [Related]
8. A phase II trial of high-dose cisplatin and dacarbazine. Lack of efficacy of high-dose, cisplatin-based therapy for metastatic melanoma.
Steffens TA; Bajorin DF; Chapman PB; Lovett DR; Cody-Johnson BV; Templeton MA; Heelan RT; Wong GY; Portlock CS; Oettgen HF
Cancer; 1991 Sep; 68(6):1230-7. PubMed ID: 1873774
[TBL] [Abstract][Full Text] [Related]
9. Temozolomide and cisplatin in avdanced malignant melanoma.
Daponte A; Ascierto PA; Gravina A; Melucci M; Scala S; Ottaiano A; Simeone E; Palmieris G; Comella G
Anticancer Res; 2005; 25(2B):1441-7. PubMed ID: 15865103
[TBL] [Abstract][Full Text] [Related]
10. Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.
von Pawel J; von Roemeling R; Gatzemeier U; Boyer M; Elisson LO; Clark P; Talbot D; Rey A; Butler TW; Hirsh V; Olver I; Bergman B; Ayoub J; Richardson G; Dunlop D; Arcenas A; Vescio R; Viallet J; Treat J
J Clin Oncol; 2000 Mar; 18(6):1351-9. PubMed ID: 10715308
[TBL] [Abstract][Full Text] [Related]
11. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
Covens A; Blessing J; Bender D; Mannel R; Morgan M;
Gynecol Oncol; 2006 Mar; 100(3):586-90. PubMed ID: 16249022
[TBL] [Abstract][Full Text] [Related]
12. Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen.
Feliu J; González Barón M; Chacón JI; Espinosa E; Garrido P; Castro J; Escobar Y; Colmenarejo A; Jara C; García Girón C; Espinosa J; Ordóñez A
Cancer Chemother Pharmacol; 1996; 38(2):191-4. PubMed ID: 8616911
[TBL] [Abstract][Full Text] [Related]
13. Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study.
Christodoulou C; Bafaloukos D; Linardou H; Aravantinos G; Bamias A; Carina M; Klouvas G; Skarlos D;
J Neurooncol; 2005 Jan; 71(1):61-5. PubMed ID: 15719277
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of tirapazamine and cisplatin in patients with recurrent cervical cancer.
Aghajanian C; Brown C; O'flaherty C; Fleischauer A; Curtin J; Roemeling R; Spriggs DR
Gynecol Oncol; 1997 Nov; 67(2):127-30. PubMed ID: 9367694
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11.
Dillman RO; Soori G; Wiemann MC; Schulof R; Dobbs TW; Ruben RH; DePriest CB; Church C
Cancer Biother Radiopharm; 2000 Oct; 15(5):487-94. PubMed ID: 11155820
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of cisplatin and alpha-interferon in advanced malignant melanoma.
Margolin KA; Doroshow JH; Akman SA; Leong LA; Morgan RJ; Somlo G; Raschko J; Pereira C; Yonemoto L; Ahn C
J Clin Oncol; 1992 Oct; 10(10):1574-8. PubMed ID: 1403037
[TBL] [Abstract][Full Text] [Related]
17. Tirapazamine with cisplatin and vinorelbine in patients with advanced non-small-cell lung cancer: a phase I/II study.
Gatineau M; Rixe O; Chevalier TL
Clin Lung Cancer; 2005 Mar; 6(5):293-8. PubMed ID: 15845180
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 and high-dose cisplatin in patients with metastatic melanoma: a pilot study.
Demchak PA; Mier JW; Robert NJ; O'Brien K; Gould JA; Atkins MB
J Clin Oncol; 1991 Oct; 9(10):1821-30. PubMed ID: 1655988
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of docetaxel in patients with advanced cutaneous malignant melanoma previously untreated with chemotherapy.
Bedikian AY; Weiss GR; Legha SS; Burris HA; Eckardt JR; Jenkins J; Eton O; Buzaid AC; Smetzer L; Von Hoff DD
J Clin Oncol; 1995 Dec; 13(12):2895-9. PubMed ID: 8523052
[TBL] [Abstract][Full Text] [Related]
20. Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Cohen EE; Rosine D; Haraf DJ; Loh E; Shen L; Lusinchi A; Vokes EE; Bourhis J
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):678-84. PubMed ID: 17293229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
